Moody’s affirms Novant Health’s bond ratings

Moody’s Investors Service has affirmed the “A1” rating assigned to Winston-Salem, N.C.-based Novant Health’s bonds and the “A1/VMIG 1” ratings assigned to its series 2004A and 2004B bonds, affecting approximately $1.1 billion.

Advertisement

The affirmation is based on a number of factors, including Novant’s large size, consistent financial performance, growing cash balances and manageable capital spending plans.

High leverage, heavy competition in Novant’s markets and a weakened financial performance may pressure the rating.

The outlook remains stable.

More articles on finance:
RCM tip of the day: Tracking outsourced RCM performance
Skytron partners with Mobile Aspects to offer RCM improvement tools
What 10k new Medicare enrollees a day means for healthcare

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.